Search

shutterstock_2261453831(1) (1)

Announcements

Announcements

HOMEWhat’s NewAnnouncements

2018.Apr.19

FDA Clearance of OBI-3424 IND Application for A Phase I/II Study Targeting AKR1C3 Solid Tumors

2018.Mar.19

OBI Pharma Inc. to attend Credit Suisse Asian Investment Conference

2018.Mar.09

Announcement on the Change of Chief Financial Officer

2018.Mar.09

OBI Pharma’s Board of Directors approves the announcement of the Company’s 2017 individual and consolidated financial statements

2018.Mar.09

The board of directors have resolved 2017 not to distribute dividends

2018.Mar.09

The Board of Directors resolved to hold 2018 Annual General Meeting

2018.Feb.23

Clarification on the news articles by Commercial Times, United Daily, etc.

2018.Jan.17

FDA Clearance of IND Application for A Phase 1 Study of A Monoclonal Antibody Cancer Immunotherapy (OBI-888)

2018.Jan.08

Shilin District Court deny OBI's request to submit the case for trial

2018.Jan.05

OBI Pharma Inc. to attend the investor conference on new drug development, hosted by Masterlink Securities

News

Latest News

Events

Latest events